KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biocryst Pharmaceuticals (BCRX) EBT Margin: 2010-2015

Historic EBT Margin for Biocryst Pharmaceuticals (BCRX) over the last 4 years, with Sep 2015 value amounting to -129.87%.

  • Biocryst Pharmaceuticals' EBT Margin rose 26584.00% to -129.87% in Q3 2015 from the same period last year, while for Sep 2015 it was -93.64%, marking a year-over-year increase of 12956.00%. This contributed to the annual value of -372.40% for FY2014, which is 16813.00% down from last year.
  • Biocryst Pharmaceuticals' EBT Margin amounted to -129.87% in Q3 2015, which was down 781.17% from 19.07% recorded in Q2 2015.
  • In the past 5 years, Biocryst Pharmaceuticals' EBT Margin registered a high of 972.33% during Q2 2012, and its lowest value of -1,618.27% during Q2 2013.
  • Its 3-year average for EBT Margin is -397.41%, with a median of -249.02% in 2014.
  • In the last 5 years, Biocryst Pharmaceuticals' EBT Margin spiked by 118,732bps in 2012 and then tumbled by 259,060bps in 2013.
  • Biocryst Pharmaceuticals' EBT Margin (Quarterly) stood at -231.97% in 2011, then soared by 118,732bps to 972.33% in 2012, then tumbled by 259,060bps to -71.50% in 2013, then crashed by 23,014bps to -301.63% in 2014, then soared by 26,584bps to -129.87% in 2015.
  • Its EBT Margin stands at -129.87% for Q3 2015, versus 19.07% for Q2 2015 and -228.95% for Q1 2015.